| Variable . | n (%) . | P-value . | n (%) . | P-value . | n (%) . | P-value . | n (%) . | P-value . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age >75 years (243 patients) . | Age ≤75 years (468 patients) . | NYHA IV (109 patients) . | NYHA I–III (602 patients) . | Urgent/emergent (192 patients) . | Elective (519 patients) . | Endocarditis (154 patients) . | No endocarditis (557 patients) . | |||||
| Mortality | 7 (2.9) | 29 (6.2) | 0.06 | 9 (8.3) | 27 (4.5) | 0.09 | 20 (10.4) | 16 (3.1) | <0.01 | 15 (9.7) | 21 (3.8) | <0.01 |
| MRCVCs | 10 (4.1) | 25 (5.3) | 0.47 | 12 (11.0) | 23 (3.8) | <0.01 | 23 (12.0) | 12 (2.3) | <0.01 | 15 (9.7) | 20 (3.6) | <0.01 |
| Revision for bleeding | 17 (7.0) | 32 (6.8) | 0.93 | 11 (10.1) | 38 (6.3) | 0.15 | 15 (7.8) | 34 (6.6) | 0.56 | 14 (9.1) | 35 (6.3) | 0.22 |
| Permanent PMK | 40 (16.5) | 50 (10.7) | 0.03 | 14 (13.0) | 76 (12.6) | 0.92 | 29 (15.1) | 61 (11.8) | 0.24 | 31 (20.1) | 59 (10.6) | <0.01 |
| Acute myocardial infarction | 4 (1.6) | 16 (3.4) | 0.17 | 4 (3.7) | 16 (2.7) | 0.54 | 7 (3.7) | 13 (2.5) | 0.41 | 4 (2.6) | 16 (2.9) | 0.86 |
| Low cardiac output syndrome | 40 (16.5) | 69 (14.7) | 0.55 | 30 (27.5) | 79 (13.1) | <0.01 | 45 (23.4) | 64 (12.3) | <0.01 | 40 (26.0) | 69 (12.4) | <0.01 |
| Perioperative IABP | 14 (5.8) | 33 (7.1) | 0.51 | 15 (13.8) | 32 (5.3) | <0.01 | 19 (9.9) | 28 (5.4) | 0.03 | 17 (11.0) | 30 (5.4) | 0.01 |
| Prolonged intubation (>48 h) | 43 (18.0) | 72 (15.6) | 0.41 | 33 (30.6) | 82 (13.8) | <0.01 | 43 (22.5) | 72 (14.1) | <0.01 | 41 (27.3) | 74 (13.4) | <0.01 |
| Acute respiratory failure | 32 (13.6) | 43 (9.2) | 0.10 | 20 (18.5) | 55 (9.2) | <0.01 | 25 (13.1) | 50 (9.7) | 0.19 | 23 (15.2) | 52 (9.3) | 0.04 |
| Pneumonia | 17 (7.0) | 32 (6.9) | 0.94 | 19 (17.4) | 30 (5.0) | <0.01 | 23 (12.0) | 26 (5.0) | <0.01 | 20 (13.0) | 29 (5.2) | <0.01 |
| Stroke | 16 (6.6) | 31 (6.7) | 0.98 | 11 (10.2) | 36 (6.0) | 0.11 | 23 (12.0) | 24 (4.6) | <0.01 | 18 (11.9) | 29 (5.2) | <0.01 |
| Acute renal insufficiency | 53 (21.8) | 84 (17.9) | 0.22 | 30 (27.5) | 107 (17.8) | 0.02 | 51 (26.6) | 86 (16.6) | <0.01 | 49 (31.8) | 88 (15.8) | <0.01 |
| CRRT | 19 (7.8) | 32 (6.8) | 0.63 | 16 (14.7) | 35 (5.8) | <0.01 | 21 (10.9) | 30 (5.8) | 0.02 | 19 (12.3) | 32 (5.7) | <0.01 |
| DSWI | 4 (1.6) | 6 (1.3) | 0.69 | 3 (2.8) | 7 (1.2) | 0.19 | 4 (2.1) | 6 (1.2) | 0.35 | 2 (1.3) | 8 (1.4) | 0.89 |
| Transfusions | 156 (64.2) | 320 (68.4) | 0.26 | 76 (69.7) | 400 (66.4) | 0.50 | 156 (81.3) | 320 (61.7) | <0.01 | 125 (81.2) | 351 (63.0) | <0.01 |
| Variable . | n (%) . | P-value . | n (%) . | P-value . | n (%) . | P-value . | n (%) . | P-value . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age >75 years (243 patients) . | Age ≤75 years (468 patients) . | NYHA IV (109 patients) . | NYHA I–III (602 patients) . | Urgent/emergent (192 patients) . | Elective (519 patients) . | Endocarditis (154 patients) . | No endocarditis (557 patients) . | |||||
| Mortality | 7 (2.9) | 29 (6.2) | 0.06 | 9 (8.3) | 27 (4.5) | 0.09 | 20 (10.4) | 16 (3.1) | <0.01 | 15 (9.7) | 21 (3.8) | <0.01 |
| MRCVCs | 10 (4.1) | 25 (5.3) | 0.47 | 12 (11.0) | 23 (3.8) | <0.01 | 23 (12.0) | 12 (2.3) | <0.01 | 15 (9.7) | 20 (3.6) | <0.01 |
| Revision for bleeding | 17 (7.0) | 32 (6.8) | 0.93 | 11 (10.1) | 38 (6.3) | 0.15 | 15 (7.8) | 34 (6.6) | 0.56 | 14 (9.1) | 35 (6.3) | 0.22 |
| Permanent PMK | 40 (16.5) | 50 (10.7) | 0.03 | 14 (13.0) | 76 (12.6) | 0.92 | 29 (15.1) | 61 (11.8) | 0.24 | 31 (20.1) | 59 (10.6) | <0.01 |
| Acute myocardial infarction | 4 (1.6) | 16 (3.4) | 0.17 | 4 (3.7) | 16 (2.7) | 0.54 | 7 (3.7) | 13 (2.5) | 0.41 | 4 (2.6) | 16 (2.9) | 0.86 |
| Low cardiac output syndrome | 40 (16.5) | 69 (14.7) | 0.55 | 30 (27.5) | 79 (13.1) | <0.01 | 45 (23.4) | 64 (12.3) | <0.01 | 40 (26.0) | 69 (12.4) | <0.01 |
| Perioperative IABP | 14 (5.8) | 33 (7.1) | 0.51 | 15 (13.8) | 32 (5.3) | <0.01 | 19 (9.9) | 28 (5.4) | 0.03 | 17 (11.0) | 30 (5.4) | 0.01 |
| Prolonged intubation (>48 h) | 43 (18.0) | 72 (15.6) | 0.41 | 33 (30.6) | 82 (13.8) | <0.01 | 43 (22.5) | 72 (14.1) | <0.01 | 41 (27.3) | 74 (13.4) | <0.01 |
| Acute respiratory failure | 32 (13.6) | 43 (9.2) | 0.10 | 20 (18.5) | 55 (9.2) | <0.01 | 25 (13.1) | 50 (9.7) | 0.19 | 23 (15.2) | 52 (9.3) | 0.04 |
| Pneumonia | 17 (7.0) | 32 (6.9) | 0.94 | 19 (17.4) | 30 (5.0) | <0.01 | 23 (12.0) | 26 (5.0) | <0.01 | 20 (13.0) | 29 (5.2) | <0.01 |
| Stroke | 16 (6.6) | 31 (6.7) | 0.98 | 11 (10.2) | 36 (6.0) | 0.11 | 23 (12.0) | 24 (4.6) | <0.01 | 18 (11.9) | 29 (5.2) | <0.01 |
| Acute renal insufficiency | 53 (21.8) | 84 (17.9) | 0.22 | 30 (27.5) | 107 (17.8) | 0.02 | 51 (26.6) | 86 (16.6) | <0.01 | 49 (31.8) | 88 (15.8) | <0.01 |
| CRRT | 19 (7.8) | 32 (6.8) | 0.63 | 16 (14.7) | 35 (5.8) | <0.01 | 21 (10.9) | 30 (5.8) | 0.02 | 19 (12.3) | 32 (5.7) | <0.01 |
| DSWI | 4 (1.6) | 6 (1.3) | 0.69 | 3 (2.8) | 7 (1.2) | 0.19 | 4 (2.1) | 6 (1.2) | 0.35 | 2 (1.3) | 8 (1.4) | 0.89 |
| Transfusions | 156 (64.2) | 320 (68.4) | 0.26 | 76 (69.7) | 400 (66.4) | 0.50 | 156 (81.3) | 320 (61.7) | <0.01 | 125 (81.2) | 351 (63.0) | <0.01 |
CRRT: continuous renal replacement therapy; DSWI: deep sternal wound infection; IABP: intra-aortic balloon pump; MRCVCs: major re-entry cardiovascular complications; PMK: pacemaker.
| Variable . | n (%) . | P-value . | n (%) . | P-value . | n (%) . | P-value . | n (%) . | P-value . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age >75 years (243 patients) . | Age ≤75 years (468 patients) . | NYHA IV (109 patients) . | NYHA I–III (602 patients) . | Urgent/emergent (192 patients) . | Elective (519 patients) . | Endocarditis (154 patients) . | No endocarditis (557 patients) . | |||||
| Mortality | 7 (2.9) | 29 (6.2) | 0.06 | 9 (8.3) | 27 (4.5) | 0.09 | 20 (10.4) | 16 (3.1) | <0.01 | 15 (9.7) | 21 (3.8) | <0.01 |
| MRCVCs | 10 (4.1) | 25 (5.3) | 0.47 | 12 (11.0) | 23 (3.8) | <0.01 | 23 (12.0) | 12 (2.3) | <0.01 | 15 (9.7) | 20 (3.6) | <0.01 |
| Revision for bleeding | 17 (7.0) | 32 (6.8) | 0.93 | 11 (10.1) | 38 (6.3) | 0.15 | 15 (7.8) | 34 (6.6) | 0.56 | 14 (9.1) | 35 (6.3) | 0.22 |
| Permanent PMK | 40 (16.5) | 50 (10.7) | 0.03 | 14 (13.0) | 76 (12.6) | 0.92 | 29 (15.1) | 61 (11.8) | 0.24 | 31 (20.1) | 59 (10.6) | <0.01 |
| Acute myocardial infarction | 4 (1.6) | 16 (3.4) | 0.17 | 4 (3.7) | 16 (2.7) | 0.54 | 7 (3.7) | 13 (2.5) | 0.41 | 4 (2.6) | 16 (2.9) | 0.86 |
| Low cardiac output syndrome | 40 (16.5) | 69 (14.7) | 0.55 | 30 (27.5) | 79 (13.1) | <0.01 | 45 (23.4) | 64 (12.3) | <0.01 | 40 (26.0) | 69 (12.4) | <0.01 |
| Perioperative IABP | 14 (5.8) | 33 (7.1) | 0.51 | 15 (13.8) | 32 (5.3) | <0.01 | 19 (9.9) | 28 (5.4) | 0.03 | 17 (11.0) | 30 (5.4) | 0.01 |
| Prolonged intubation (>48 h) | 43 (18.0) | 72 (15.6) | 0.41 | 33 (30.6) | 82 (13.8) | <0.01 | 43 (22.5) | 72 (14.1) | <0.01 | 41 (27.3) | 74 (13.4) | <0.01 |
| Acute respiratory failure | 32 (13.6) | 43 (9.2) | 0.10 | 20 (18.5) | 55 (9.2) | <0.01 | 25 (13.1) | 50 (9.7) | 0.19 | 23 (15.2) | 52 (9.3) | 0.04 |
| Pneumonia | 17 (7.0) | 32 (6.9) | 0.94 | 19 (17.4) | 30 (5.0) | <0.01 | 23 (12.0) | 26 (5.0) | <0.01 | 20 (13.0) | 29 (5.2) | <0.01 |
| Stroke | 16 (6.6) | 31 (6.7) | 0.98 | 11 (10.2) | 36 (6.0) | 0.11 | 23 (12.0) | 24 (4.6) | <0.01 | 18 (11.9) | 29 (5.2) | <0.01 |
| Acute renal insufficiency | 53 (21.8) | 84 (17.9) | 0.22 | 30 (27.5) | 107 (17.8) | 0.02 | 51 (26.6) | 86 (16.6) | <0.01 | 49 (31.8) | 88 (15.8) | <0.01 |
| CRRT | 19 (7.8) | 32 (6.8) | 0.63 | 16 (14.7) | 35 (5.8) | <0.01 | 21 (10.9) | 30 (5.8) | 0.02 | 19 (12.3) | 32 (5.7) | <0.01 |
| DSWI | 4 (1.6) | 6 (1.3) | 0.69 | 3 (2.8) | 7 (1.2) | 0.19 | 4 (2.1) | 6 (1.2) | 0.35 | 2 (1.3) | 8 (1.4) | 0.89 |
| Transfusions | 156 (64.2) | 320 (68.4) | 0.26 | 76 (69.7) | 400 (66.4) | 0.50 | 156 (81.3) | 320 (61.7) | <0.01 | 125 (81.2) | 351 (63.0) | <0.01 |
| Variable . | n (%) . | P-value . | n (%) . | P-value . | n (%) . | P-value . | n (%) . | P-value . | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age >75 years (243 patients) . | Age ≤75 years (468 patients) . | NYHA IV (109 patients) . | NYHA I–III (602 patients) . | Urgent/emergent (192 patients) . | Elective (519 patients) . | Endocarditis (154 patients) . | No endocarditis (557 patients) . | |||||
| Mortality | 7 (2.9) | 29 (6.2) | 0.06 | 9 (8.3) | 27 (4.5) | 0.09 | 20 (10.4) | 16 (3.1) | <0.01 | 15 (9.7) | 21 (3.8) | <0.01 |
| MRCVCs | 10 (4.1) | 25 (5.3) | 0.47 | 12 (11.0) | 23 (3.8) | <0.01 | 23 (12.0) | 12 (2.3) | <0.01 | 15 (9.7) | 20 (3.6) | <0.01 |
| Revision for bleeding | 17 (7.0) | 32 (6.8) | 0.93 | 11 (10.1) | 38 (6.3) | 0.15 | 15 (7.8) | 34 (6.6) | 0.56 | 14 (9.1) | 35 (6.3) | 0.22 |
| Permanent PMK | 40 (16.5) | 50 (10.7) | 0.03 | 14 (13.0) | 76 (12.6) | 0.92 | 29 (15.1) | 61 (11.8) | 0.24 | 31 (20.1) | 59 (10.6) | <0.01 |
| Acute myocardial infarction | 4 (1.6) | 16 (3.4) | 0.17 | 4 (3.7) | 16 (2.7) | 0.54 | 7 (3.7) | 13 (2.5) | 0.41 | 4 (2.6) | 16 (2.9) | 0.86 |
| Low cardiac output syndrome | 40 (16.5) | 69 (14.7) | 0.55 | 30 (27.5) | 79 (13.1) | <0.01 | 45 (23.4) | 64 (12.3) | <0.01 | 40 (26.0) | 69 (12.4) | <0.01 |
| Perioperative IABP | 14 (5.8) | 33 (7.1) | 0.51 | 15 (13.8) | 32 (5.3) | <0.01 | 19 (9.9) | 28 (5.4) | 0.03 | 17 (11.0) | 30 (5.4) | 0.01 |
| Prolonged intubation (>48 h) | 43 (18.0) | 72 (15.6) | 0.41 | 33 (30.6) | 82 (13.8) | <0.01 | 43 (22.5) | 72 (14.1) | <0.01 | 41 (27.3) | 74 (13.4) | <0.01 |
| Acute respiratory failure | 32 (13.6) | 43 (9.2) | 0.10 | 20 (18.5) | 55 (9.2) | <0.01 | 25 (13.1) | 50 (9.7) | 0.19 | 23 (15.2) | 52 (9.3) | 0.04 |
| Pneumonia | 17 (7.0) | 32 (6.9) | 0.94 | 19 (17.4) | 30 (5.0) | <0.01 | 23 (12.0) | 26 (5.0) | <0.01 | 20 (13.0) | 29 (5.2) | <0.01 |
| Stroke | 16 (6.6) | 31 (6.7) | 0.98 | 11 (10.2) | 36 (6.0) | 0.11 | 23 (12.0) | 24 (4.6) | <0.01 | 18 (11.9) | 29 (5.2) | <0.01 |
| Acute renal insufficiency | 53 (21.8) | 84 (17.9) | 0.22 | 30 (27.5) | 107 (17.8) | 0.02 | 51 (26.6) | 86 (16.6) | <0.01 | 49 (31.8) | 88 (15.8) | <0.01 |
| CRRT | 19 (7.8) | 32 (6.8) | 0.63 | 16 (14.7) | 35 (5.8) | <0.01 | 21 (10.9) | 30 (5.8) | 0.02 | 19 (12.3) | 32 (5.7) | <0.01 |
| DSWI | 4 (1.6) | 6 (1.3) | 0.69 | 3 (2.8) | 7 (1.2) | 0.19 | 4 (2.1) | 6 (1.2) | 0.35 | 2 (1.3) | 8 (1.4) | 0.89 |
| Transfusions | 156 (64.2) | 320 (68.4) | 0.26 | 76 (69.7) | 400 (66.4) | 0.50 | 156 (81.3) | 320 (61.7) | <0.01 | 125 (81.2) | 351 (63.0) | <0.01 |
CRRT: continuous renal replacement therapy; DSWI: deep sternal wound infection; IABP: intra-aortic balloon pump; MRCVCs: major re-entry cardiovascular complications; PMK: pacemaker.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
